Agilent Technologies (A) to Release Earnings on Wednesday

Agilent Technologies (NYSE:A - Get Free Report) is anticipated to post its Q2 2025 quarterly earnings results after the market closes on Wednesday, May 28th. Analysts expect Agilent Technologies to post earnings of $1.27 per share and revenue of $1.63 billion for the quarter. Agilent Technologies has set its Q2 2025 guidance at 1.250-1.280 EPS and its FY 2025 guidance at 5.540-5.610 EPS.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Agilent Technologies Trading Up 0.0%

NYSE A opened at $113.48 on Wednesday. The stock has a market capitalization of $32.35 billion, a price-to-earnings ratio of 26.09, a PEG ratio of 3.21 and a beta of 1.27. Agilent Technologies has a one year low of $96.43 and a one year high of $154.65. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The business's fifty day moving average is $110.23 and its 200-day moving average is $127.89.

Insider Buying and Selling

In related news, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now directly owns 35,737 shares of the company's stock, valued at $4,161,931.02. This trade represents a 4.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05% decrease in their position. The disclosure for this sale can be found here.

Institutional Investors Weigh In On Agilent Technologies

A hedge fund recently raised its stake in Agilent Technologies stock. Brighton Jones LLC grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 6.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,663 shares of the medical research company's stock after purchasing an additional 270 shares during the period. Brighton Jones LLC's holdings in Agilent Technologies were worth $626,000 at the end of the most recent reporting period.

Analysts Set New Price Targets

Several brokerages have recently commented on A. Wells Fargo & Company cut their price objective on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a report on Thursday, April 17th. Barclays cut their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Robert W. Baird dropped their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research report on Thursday, February 27th. Jefferies Financial Group dropped their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Finally, TD Cowen boosted their price objective on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $143.00.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.